
Rosies Base, a start-up R&D company developing bio-compatible, durable and cost-effective nano-structured alloys for use in medical devices, signed a research agreement with SpineCraft to investigate the compatibility and effectiveness of nanoTi in the manufacture of spinal implant rods.
Rosies Base claims to be the world’s only supplier of nanoTi, a titanium alloy created through a proprietary metallurgical rolling process that delivers ultra-fine-grained metal alloys that are reportedly thinner and stronger than standard alloys, with anti-microbial properties that resist the formation of biofilms on implanted devices. The company’s first product, nanoSUS, is a nano-structured stainless steel designed to offer higher strength than conventional surgical-grade stainless steel, with claims of improved processing capabilities and novel biological properties.
“Nano-structured metals offer a variety of advantages over conventionally produced alloys, including higher strength, improved processing capabilities, and novel biological properties,” said Fumie Yusa, Ph.D., Vice President and COO of Rosies Base. “We expect our partnership with SpineCraft, a leader in the spinal orthopedics field, to demonstrate the superiority of our nanoTi alloy compared with conventional medical-grade titanium.”
Source: Rosies Base
JAV
Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.